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Abstract
Objective—To determine the effect of oxygen fluctuations on the expression of vascular
endothelial growth factor (VEGF) and VEGF receptor 1(R1) and VEGFR2 using a rat model of
retinopathy of prematurity (ROP).
Methods—Retinas isolated from the ROP model and from room air-raised rat pups (RA) at
several post-natal day ages (p) were analyzed for mRNAs of VEGF splice variants, VEGFR1 and
VEGFR2 by real-time polymerase chain reaction (PCR). VEGF protein was measured by ELISA.
Results—Older developmental age was associated with increased expression of VEGFR1 and
VEGF120 mRNAs (P<.0001 and P=.0006, respectively). VEGFR2 and VEGF164 mRNAs were
associated with older developmental age (P<.0001) or exposure to the ROP model (P=.0247 and
P<.0001, respectively). VEGF120 and VEGF164 had greater mRNA expression at p14 when 30%
avascular retina existed in the ROP model compared to RA in which no avascular retina existed,
and at p18 when intravitreous neovascularization existed in the model but not in RA. VEGF
protein was significantly increased at p14 and at p18 (P<.0001).
Conclusions—Unlike models of oxygen-induced retinopathy that describe ROP prior to
implementation of oxygen regulation, the ROP model recreates oxygen stresses relevant to
preterm infants with severe ROP today. VEGF164 and VEGFR2 mRNA expression and VEGF
protein were increased in association with the ROP model and older developmental age and at
time points when not only intravitreous neovascularization, but also avascular retina, were present
in the ROP model and not in RA, suggesting a role for VEGF regulation in the development of
these features.
Introduction
Retinopathy of prematurity (ROP), described in the 1940's1, was attributed to high oxygen at
birth that caused newly developed retinal capillaries to constrict and recess leaving areas of
avascular retina2,3. When a preterm infant was moved from an oxygen environment to room
air, the avascular retina became hypoxic and was thought to be the source of angiogenic
factors that caused intravitreous neovascularization (IVNV). This hypothesis2,4,3 was
developed through experimentation with newborn animals exposed to constant, high oxygen
followed by room air exposure and provided the basis for several oxygen-induced
retinopathy (OIR) models still used today. Smith et al. developed a widely used mouse OIR
model, which many investigators have used to determine mechanisms of oxygen stress and
relative hypoxia-induced angiogenesis with genetically modified animals5. The model has
also been used to reflect a transition from in utero with low oxygen and maternally-derived
factors to sometime after birth when oxygen levels were higher6, and growth factors,
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inadequately produced by the infant, were no longer supplied from the placental
circulation7. Also, using the model, Smith proposed a biphasic scenario for severe ROP, in
which initially there was a “vaso-obliterative phase” (seen as hyperoxia-induced central
avascular retina in the mouse OIR model) followed by a “vaso-proliferative phase” (seen as
endothelial budding into the vitreous at the junctions of avascular and vascular retina).
For the most part, the mouse OIR model represents ROP in preterm infants exposed to high,
unregulated oxygen levels (such as seen in the 1940's in the US) or to infants with delayed
retinal vascular development, low growth factor levels8 and poor postnatal growth9.
However, the mouse model may not represent most cases of severe ROP that occur in the
US today. First, since the initial description of ROP and recognition that high oxygen at
birth played a role, technology has developed and been implemented to regulate and monitor
oxygen in preterm infants. Now, preterm infants are no longer resuscitated in high oxygen6
and oxygen saturations are carefully monitored to keep them in the mid 80 to low 90
percentages, depending on the post-gestational age of the infant (these saturations translate
to arterial concentrations under 70 mm Hg). In oxygen-induced retinopathy models,
including the mouse model, 75% inspired oxygen is used to induce capillary recession and
constriction, and this level of inspired oxygen causes arterial oxygen levels higher than 300
mmHg10. Second, in most OIR models, constant oxygen, rather than fluctuations in oxygen,
is used. However, oxygen levels in the preterm human infant fluctuate on a minute-to-
minute frequency even when inspired oxygen is relatively constant, and the extremes of
oxygen levels as well as the range of the fluctuations may play a role in human ROP11.
Third, in the human infant, retinal vascular development to the ora serrata is complete at
term, but preterm infants have incomplete vascularization of the retina at birth. With today's
ROP, there appears to be a delay in vascularization of avascular retina with areas of
peripheral avascular retina and not central “vaso-obliteration” that is a main feature in the
mouse OIR model.
Molecular analyses of retinas of the mouse OIR model have reported reduced expression of
several growth factors during the “vaso-obliterative phase” of avascular retina12,13.
Particularly notable is vascular endothelial growth factor (VEGF), an important factor in
retinal vascular development14,15,16 and in pathologic angiogenesis17. When VEGF or other
factors, including erythropoietin, insulin-like growth factor-1 (IGF-1), or placental growth
factor, were injected into the vitreous of an eye in the mouse OIR model prior to hyperoxia,
central retinal avascularity was reduced. During the proliferative phase, expression of
VEGF, erythropoietin or IGF-1 was increased in association with intravitreous endothelial
budding, and inhibition of growth factor bioactivity by several methods led to reduced
endothelial budding18,19,20,21. In the OIR model, the time period between the two events is
within 10 days, whereas in preterm infants severe ROP develops approximately 2 months or
more following birth. It is unknown what happens to the retinal growth factor concentration
in the human infant during this interval.
To explore the effect of relevant oxygen stresses on the regulation of VEGF splice variants
and receptors in association with important features of severe ROP seen today in the US, we
used a relevant model, which exposes pups to oxygen levels that produce arterial oxygen
concentrations similar to transcutaneous oxygen levels reported in infants with severe ROP
in current day22. The model also produces a characteristic appearance of severe ROP with
peripheral avascular retina similar to zone II ROP22,23, followed by retinal tortuosity similar
to plus disease24, and then intravitreous neovascularization (IVNV) at the junctions of
vascular and avascular retina, similar to stage 3 ROP25,23. The model uses fluctuations in
oxygen, a risk factor for severe ROP11. We measured retinal VEGF protein and the
expression of VEGF splice variant and receptor mRNAs in the model and in room air at the
same developmental ages.
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All animal studies complied with the University of North Carolina's Institute for Laboratory
Animal Research (Guide for the Care and Use of Laboratory Animals) and the ARVO
Statement for the Use of Animals in Ophthalmic and Visual Research.
ROP Model
Within 4 hours of birth at postnatal day 0 (p0), litters of 12-14 newborn Sprague-Dawley rat
pups with their mothers (Charles River, Wilmington, MA) were placed into an Oxycycler
incubator (Biospherix, New York, NY) to cycle inspired oxygen between 50% oxygen and
10% oxygen every 24 hours. Pups from other litters were used to supplement deficient
litters. After 7 cycles of oxygen fluctuations at day 14, pups were then placed into room air
for 4 days10. Oxygen levels were monitored daily and recalibrated as needed. Carbon
dioxide in the cage was also monitored daily and was flushed from the system by
maintaining sufficient gas-flow and by adding soda lime, if needed.
Dissection of Retinal Tissue for Flat Mounting and mRNA and Protein Analyses
For time point measurements, animals were euthanized with pentobarbital (80 mg/kg
intraperitoneal injection) at the time of change in inspired oxygen level. Therefore, pups
euthanized at the start of even numbered days up to day 14 had just been exposed to 10%
oxygen and odd numbered days, to 50% oxygen. Pups euthanized at day 18 had been
exposed to 7 cycles of oxygen fluctuations followed by 4 days in room air. (As an example,
a postnatal day 8 pup was starting the 8th day of life and had just been exposed to 10%
oxygen.) For flat mounts, eyes were fixed in 2% paraformaldehyde (PFA) for 2 hours.
Retinas were isolated26 with ora serratas intact and placed into phosphate buffered saline
(PBS) after the hyaloidal vessels and remaining vitreous were removed. By making 4
incisions 90 degrees apart, the retinas were flattened and then placed onto microscope slides.
For fresh tissue, eyes were not fixed in PFA and retinas were dissected without ora serratas.
Tissue was frozen in modified radioimmunoprecipitation assay (RIPA) buffer (20 mM Tris
base, 120 mM sodium chloride (NaCl), 1% Triton X-100, 0.5% sodium deoxycholate, 0.1%
sodium dodecyl sulfate (SDS), 10% glycerol) with a Protease inhibitor cocktail (1:100,
Sigma, MO) and 1M orthovanadate (1:100, Sigma, MO), then stored at -20°C for protein or
RNAlater (Applied Biosystems, CA) for RNA until analysis.
Tissue Staining and Analysis of Flat Mounts
To stain the vasculature, the flattened retinas were first permeabilized in ice cold 70% v/v
ethanol for 20 minutes, then in PBS/1% Triton x-100 for 30 minutes, and then incubated
with Alexa Fluor 568 conjugated G. simplicifolia (Bandeiraea) isolectin B4 (5 μg/ml,
Molecular Probes, OR) in PBS overnight at 4°C, as previously described27. Images of the
retinal blood vessels were captured using a Nikon 80i Research Upright Microscope with
Surveyor/Turboscan software and digitally stored for analysis.
Total retinal area, summed peripheral avascular retinal area and areas of IVNV were
computed in pixels with Image Tool v.3 (University of Texas, San Antonio, TX) and
converted to mm2 (using a calibration bar on each image). IVNV was defined as
neovascularization growing into the vitreous at the junction of vascular and avascular
retina23. For clock hours, flat mounts were divided into 12 clock hours of approximately
equal area using Adobe Photoshop, assessed for the presence of IVNV28,29, and assigned a
number (0 to 12) depending on the number of clock hours exhibiting IVNV. Areas were
measured, summed, and expressed as a percent of total retinal area for each eye.
Measurements were performed by two independent masked reviewers. When discrepancies
in measurements occurred, these were reviewed and a final consensus determined.
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Samples were removed from RNAlater and total RNA was extracted using the RNeasy Mini
kit (Qiagen, Valencia, CA). DNA contamination was removed by using DNA-free (Ambion,
Austin,TX), and RNA quantity was determined spectrophotometrically. 1 μ g of RNA from
each sample was reverse transcribed using the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems, Foster City, CA). Approximately 200 ng of cDNA were analyzed
per well by one step real time PCR using the TaqMan MasterMix with reverse transcriptase
(3.7 U/reaction, Applied Biosystems, Foster City, CA). Primers were specific for rat
(annealing temperature 60°C): VEGF164: forward 5′GCACATAGGAGAGATGAGCT 3′,
probe 5′GCTCACAGTGATTTT CTGGC3′, reverse TGCAG
CATAGCAGATGTGAATGCAGACC, VEGF120: forward 5′GCACATAGGAGA G
ATGAGCT 3′, probe 5′GGCTTGTCACATTTTTCTGGC3′, reverse
TGCAGCATAGCAGATGTGA ATGCAGACC, VEGF188: forward,
5′CAGTTCGAGGAAAGGGAAAG 3′, probe, 5′CAGTGAACGCTCCAGGATTT3′,
reverse ACCGGGATTTC TTGCGCTTTCGTTTTTTG, VEGFR1: forward,
5′CCACCTCCATGTTTGAAGAC3′, probe, 5′AGTCCAGGTGAATC GCTTCA3′,
reverse TACCAGCAGTCTGCTGACCTCCCC, VEGFR2: forward
5′CTCCATCTTTTGGTGGGATG3′, probe 5′GCTGGTCTGGTTGGAGCCT3′, reverse
AGGCCACAGACTCCCTGCTT TTACTG3, and were made by UNC's Oligonucleotide
Core facility (http://www.med.unc.edu/olioli/index.htm). cDNA was mixed 1:1 with
Taqman Universal Master Mix (Applied Biosystems, CA) and primers. Rat β-actin was used
as a control gene because its expression had been found to be stable under various oxygen
stresses previously. Primers for rat β-actin were, forward, TGCCTGACGGTCAGGTCA,
probe CACTATCGGCAATGAGCGGTTCCG, and reverse
CAGGAAGGAAGGCTGGAAG. Duplicate reactions with a total volume of 16 μL were
run for each sample and control using the AB 7500 PCR System. The 7500 System Software
calculates cycle threshold (Ct) automatically for each well and each value was normalized to
β-actin. DDCt values were then calculated. The p0 time point was within 4 hours of birth
and was therefore the same time point for samples from room air pups and those in the ROP
model. VEGF188 at p0 was assigned a value of 1.0. The values for the three VEGF splice
variants in the ROP model and room air were related to this value and graphically
represented (Figures 4 – 6). VEGFR1 room air at p0 was scaled to the value of 1.0 for
comparisons of time points for room air and the 50/10 OIR model for VEGFR1 (Figure 2).
The VEGFR2 value at p0 was 59.6 fold greater than VEGFR1. VEGFR2 room air at p0 was
scaled to the value of 1.0 for comparisons of time points for room air and the 50/10 OIR
model for VEGFR2 (Figure 3). For statistical analysis, raw data were used.
Protein Analysis
VEGF protein was analyzed with an enzyme-linked immunosorbent assay (ELISA), which
measures all VEGF splice variants. The most prevalent splice variants represent the greatest
percentage in the ELISA value. Retinal samples frozen in RIPA buffer were thawed,
homogenized and centrifuged (16,000×g, 10 minutes, 4°C). Total protein was quantified
with a bicinchoninic acid (BCA) protein assay kit (Bio-Rad, Hercules, CA, modified from
the Lowry assay30). Supernatants were assayed without dilution in duplicate using
commercially available ELISA kits, raised against rat VEGF (R& D systems, MN). The
mean minimum detectable dose was 6.4 pg/mL for VEGF.
Analysis
In order to maintain the reproducibility of the ROP model, litters were never depleted below
12 pups. Often this required that whole litters be used for individual time points. For each
time point, at least 5 retinas from different pups were analyzed from at least two different
litters. Graphically represented are the mean fold changes relative to β-actin with error bars
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representing standard errors. While these normalized ratios were used for graphical
representation in the figures, in order to avoid bias, the raw data were rescaled and
statistically analyzed as described below.
Initially, β-actin was analyzed by regression analysis of the ratio of each β-actin/VEGF
splice variant or receptor mRNA for the Ct1 value against respective β-actin/VEGF splice
variant or receptor mRNA for the Ct2 value, and the slope was found to be indistinguishable
from 1.0, which is the ideal value31. The geometric means of the product of the two ratios
were then determined for each time point and treatment, and this was the outcome analyzed.
For the analysis of VEGF protein by ELISA, the protein concentration was the outcome
analyzed. A factorial analysis of variance (ANOVA) with a completely randomized
treatment arrangement was used to determine the significance of the factors, time point and
treatment (room air vs. ROP model) as well as the interaction of time point and treatment.
Post-hoc testing of treatment and time point by treatment interaction means was
accomplished using protected t tests on least squares means, with alpha level adjustment for
multiple comparisons among means accomplished using a method of simulation32.
Results
Retinal Flat Mounts
In p14 room air-raised pups, retinal vascularization of the inner capillary plexus had
extended to the ora serrata (Figure1a). There was no avascular retina or IVNV at p14 or p18
in room air. In the ROP model, avascular retina was approximately 30% of the total retinal
area at p14, and 25% at p18. No clock hours of IVNV were found at p14 and a median of
7.0 clock hours (3.2± 0.3 mm2 mean avascular area ± standard error) was present at p18
(Figure 1b). These findings are comparable to those reported in the literature33.
mRNAs of VEGF Receptors and VEGF Splice Variants
We chose time points to determine expression levels preceding and including postnatal day
(p)14 when avascular retina was present in the ROP model, but absent in room air raised
pups. We also analyzed p18 for IVNV. A previous study has reported on VEGF protein
concentration at time points following p14 and preceding the development of IVNV in the
ROP model29.
VEGFR1 mRNA increased many fold during development (Figure 2). For example, from p0
to p14, VEGFR1 mRNA increased 42 fold and from p0 to p18, 75 fold. By statistical
analysis, increased fold expression of VEGFR1 was significantly associated with older
developmental age (P<.0001), but not with whether pups had been placed into the ROP
model or room air. In contrast, the fold increase in VEGFR2 mRNA was relatively less than
for VEGFR1 mRNA. For example, from p0 to p14, VEGFR2 mRNA increased
approximately 5 fold and from p0 to p18, approximately 3 fold (Figure 3). Furthermore,
there was a significant increase in expression associated with older developmental age (P<.
0001) and with exposure to the ROP model compared to room air (P=.0247).
We previously reported that VEGF164 was the most prevalent and VEGF188 the least
prevalent splice variant in the ROP model using relative quantitative RT-PCR33. Using real
time PCR, we confirmed these findings. Since VEGF expression was reduced during the
“vaso-obliterative” phase in the mouse OIR model, we predicted that the most prevalent
VEGF splice variant, VEGF164, would have lower fold expressions in the ROP model at the
developmental age when avascular retina existed in the ROP model compared to room air
when no avascular retina was present. However, the fold expression in VEGF164 mRNA
was greater in the ROP model than in room air at p14. By statistical analysis of VEGF164,
there was a significant increase in expression associated with older developmental age (P<.
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0001) and with exposure to the ROP model compared to room air (P<.0001). Since VEGF is
upregulated in hypoxia and downregulated in hyperoxia34, we anticipated that the pattern of
VEGF164 expression would show a greater fold expression following 24 hours in hypoxia
(p12 and p14) and a lower fold expression following 24 hours in hyperoxia (p11 and p13).
As predicted, the pattern of VEGF164 expression varied based on whether hypoxia or
hyperoxia had occurred in the ROP model (Figure 4). In agreement with our predictions, at
p18 when IVNV was present in the ROP model, the VEGF164 expression was greater in the
ROP model than in room air. For VEGF120, the pattern of upregulation following hypoxia
and downregulation following hyperoxia was also noted (Figure 5). However, by statistical
analysis, only older developmental age was significantly associated with increased
expression of VEGF120 (P=.0006). There was no significant association with exposure to the
ROP model compared to room air (P=.61). VEGF188 had greater fold expression at most
time points in room air compared to the ROP model, but there was no significant association
with developmental age or with exposure to the ROP model compared to room air (Figure
6).
VEGF Protein Concentration in Room Air and ROP Model—VEGF protein was
significantly associated with older developmental age or with exposure to the ROP model
compared to room air (both P<.0001). VEGF protein shared some similarities in the pattern
of expression as fold changes in VEGF164 mRNA (Figure 7). By Post-hoc testing, there was
significant increases in VEGF protein in the ROP model compared to room air at both p14
and p18 (P<.0001).
Discussion
We analyzed retinal mRNA expression of VEGF splice variants, VEGFR1 and VEGFR2,
and of VEGF protein at different developmental time points in room air and in a rat ROP
model that uses oxygen extremes and fluctuations relevant to human preterm infants, who
develop severe ROP today. This model also has a retinal appearance similar to human zone
II, stage 3 ROP. We found that increased expression of VEGF164 was significantly
associated with older developmental age or exposure to the ROP model compared to room
air, whereas increased expression of VEGF120 was significantly associated with older
developmental age and not with exposure to the ROP model. The fold changes of the least
prevalent splice variant, VEGF188, were not significantly affected by developmental age or
exposure to the ROP model compared to room air. VEGFR1 expression was significantly
increased in association with older developmental age, but not with exposure to the ROP
model, whereas VEGFR2 expression was significantly increased in association with older
developmental age or with exposure to the ROP model.
We previously reported that VEGF164 expression, measured with relative quantitative RT-
PCR, was increased after repeated fluctuations in oxygen but not after a single episode of
10% oxygen exposure, whereas VEGF120 was upregulated following an episode of hypoxia
and not after repeated fluctuations in oxygen 33. As fluctuations in transcutaneous oxygen
are associated with increased risk of severe ROP11, the data from these reports suggest that
VEGF164 may be the splice variant most associated with pathologic features in ROP.
VEGFR2 is believed to be the receptor most involved in angiogenic processes, whereas
VEGFR1 is believed to trap VEGF and limit its signaling through VEGFR2 in development.
Our data show VEGFR2, but not VEGFR1, as significantly upregulated in association with
the ROP model.
We also found that VEGF protein concentration was significantly greater in the ROP model
than room air at p14 when avascular retina existed in the ROP model, but vascularization of
the inner retinal plexus had extended to the ora serrata in room air. These findings were
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unexpected and contrast with other models of oxygen-induced retinopathy5 in which VEGF
expression was reduced following hyperoxia-induced avascular retina, and increased with
relative hypoxia-induced endothelial cell proliferation into the vitreous12,13. The early
concept of hyperoxia induced “vaso-obliteration” is clinically not observed in zone II, stage
3 severe ROP. Rather, there appears to be incomplete vascular development associated with
preterm birth followed by a delay in peripheral retinal vascularization and then abnormal
angiogenic patterning and proliferation at the junction of vascular and avascular retina. We
did find that VEGF was significantly increased in the ROP model when IVNV occurred.
However, using the ROP model, our findings do not fit the biphasic hypothesis in that we
found increased VEGF in association with both avascular retina and IVNV.
Previously using the ROP model, increased VEGF-VEGFR2 signaling was found associated
with first arteriolar tortuosity and venous dilation, similar in appearance to human plus
disease, followed by IVNV, and both were reduced by inhibiting the bioactivity of VEGF
with an intravitreous injection of a neutralizing antibody to VEGF28,35. Since VEGF is an
angiogenic agonist, both IVNV and intraretinal vascularization would be anticipated to be
reduced by an agent to inhibit VEGF bioactivity or signaling. However, neither a
neutralizing antibody to VEGF28 nor a VEGFR2 tyrosine kinase inhibitor27 were found to
interfere with ongoing intraretinal vascularization in the ROP model even though each
intervention significantly reduced IVNV. Also, in a series of human infants with mostly
zone II, stage 3 severe ROP, single injections of intravitreous bevacizumab were reported to
cause regression of stage 3 ROP and permit ongoing retinal vascularization toward the ora
serrata36. These studies along with our data suggest that excessive VEGF-VEGFR2
expression and/or signaling are associated with IVNV and greater avascular retinal area in
the ROP model and in some cases of severe human ROP. Further study is warranted.
The processes of developmental and aberrant angiogenesis are complex, involving a number
of interacting factors. However, VEGF has been recognized as one of the most important in
human retinal diseases associated with pathologic angiogenesis.37,38 VEGF is upregulated
by hypoxia and ischemia34 and is increased in the serum and vitreous of patients with
intravitreous neovascularization, including ROP39,17. Also, in a human infant with stage 3
ROP, VEGF mRNA was detected in the avascular retina40. Other pathways, including the
delta-like ligand 4/Notch1 signaling pathway, can regulate the numbers of VEGF-induced
endothelial tip cells to stalk cells at the junction of vascular and avascular retina and permit
developmental angiogenesis41,42. Other angiogenic factors including erythropoietin, IGF-1,
tumor necrosis factor, and hypoxia inducible factor-1α (HIF-1α), angiopoietins, tumor
necrosis factor alpha, hepatocyte growth factor43,20,44,45 have been reported to play a role in
oxygen-induced retinopathy. Inhibitors, such as thrombospondin-146 and PEDF47, may also
be important. Interactions of growth factors and of other cells, such as pericytes, astrocytes
and other glia48,49 are important. Signaling events can affect endothelial tip cell filopodia
number and length at the migrating front27 and affect the patterning of vessels50.
Direct comparisons between mathematical fold changes in expression of mRNAs with
biologic outcomes fail to take into account signaling cascades. Variability in measurements
can also occur within the oxygen cycle and reflect the time for protein translation, post-
translational modification of protein, stability of mRNA, and sequestration of growth factor
within extracellular matrix following mRNA upregulation. For the receptors, commercially
available antibodies that recognize rat have not produced consistent results. Future studies of
receptor protein and signaling will be important. Despite limitations, these data are useful to
refine hypotheses on features of severe ROP seen today.
VEGF188 mRNA was expressed in room air to a greater degree than in retinas from the ROP
model. This splice variant is cell-associated, and its expression may reflect the vascular
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coverage of the retina. There was also upregulation following hypoxia, a finding we had
reported previously with relative quantitative RT-PCR33. However, there were no significant
statistical associations between VEGF188 and either developmental age or exposure to the
ROP model.
In conclusion, we used a model that represents zone II, stage 3 severe ROP as observed in
countries like the US where oxygen regulation and monitoring are implemented in neonatal
intensive care units. We found that the expressions of splice variant VEGF164 and VEGFR2
were significantly increased in association with older developmental age and exposure to the
ROP model compared to room air, whereas VEGF120 and VEGFR1 were increased in
association with older developmental age. The fold change of VEGF164 expression and the
concentration of VEGF protein were greater in the ROP model at p14 when there was about
30 percent avascular retina compared to room air when the inner vascular plexus had
extended to the ora serrata. Additional studies are needed to explore the association of
increased VEGF with avascular retina.
Although this study supports others in the literature that excessive VEGF signaling is
involved in the pathology of zone II, stage 3 severe ROP, the following considerations
should be made before using anti-VEGF agents in the preterm infant eye. Inhibiting VEGF
bioactivity in the preterm infant undergoing retinal and neurologic development may have
adverse consequences, because VEGF is both a neuronal and endothelial survival
factor51,52,53. Also, the development of the lung54 requires VEGF and preterm infants are at
risk for pulmonary disease. In addition, circulating drug levels are likely to be higher in
infants than adults, because infants have relatively much smaller blood volumes than adults
compared to the differences between respective vitreous volumes23. This study describes a
model of zone II, stage 3 ROP and may not be relevant to other severe forms of ROP, such
as aggressive posterior ROP. Finally, the Early Treatment Retinopathy of Prematurity Trial
reported that laser treatment of type 1 prethreshold ROP was associated with 90% success55.
Therefore, clinical trials are needed to test agents against the current standard of care.
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Lectin-stained retinal flat mounts created by 4 relaxing incisions showing retinal
vascularization in rat. A). Room air raised pup at postnatal day (p)14 rat has retinal
vascularization that extends to the ora serrata.
B) ROP model at p18 following 7 cycles of oxygen fluctuations between 50% and 10% and
then 4 days in room air, showing avascular retina and intravitreous neovascularization
(IVNV). Optic nerve is in the center (no macula is present in rat) and peripheral avascular
retina seen adjacent to the ora serrata.
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Real time PCR mean values for VEGF Receptor (R)1 of rat pups from p0 through p18 in
room air development (RA) or in the ROP model (ROP). In the ROP model, p8, p12, and
p14 occur immediately following hypoxia (10% FiO2) and p11 and p13 following hyperoxia
(50% FiO2). Following p14, pups are in room air (21% FiO2). All values are normalized to
β-actin and are compared to p0, which is the same for room air and ROP. There was a
significant increase in expression associated with older developmental age (P<.0001) but not
with exposure to the ROP model compared to age-matched room air pups (P=.82). The
value for VEGFR1 at p0 was scaled to 1.0 to allow comparisons among VEGFR1 values in
room air or ROP. The graph represents means and standard errors for each room air and
ROP time point, each time point having an n=at least 5 retinas from different pups taken
from at least 2 litters.
Budd et al. Page 13














Real time PCR mean values for VEGF Receptor (R)2 of rat pups from p0 through p18 in
room air development (RA) or in the ROP model (ROP). In the ROP model, p8, p12, and
p14 occur immediately following hypoxia (10% FiO2) and p11 and p13 following hyperoxia
(50% FiO2). Following p14, pups are in room air (21% FiO2). All values are normalized to
β-actin and are compared to p0 which is the same for room air and OIR. There was a
significant increase in VEGFR2 expression associated with older developmental age (P<.
0001) and with exposure to the ROP model compared to age-matched room air pups (P=.
0247). The value for VEGFR2 at p0 was scaled to 1.0 to allow comparison among VEGFR2
values in room air or ROP. The graph represents means and standard errors for each room
air and ROP time point, each time point having an n=at least 5 retinas from different pups
taken from at least 2 litters.
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Real time PCR mean values for VEGF splice variant VEGF164 of rat pups from selected
postnatal days (p) 0 through p18 in room air development (RA) or in the ROP model (ROP).
In the ROP model, p8, p12, and p14 occur immediately following hypoxia (10% FiO2) and
p11 and p13 following hyperoxia (50% FiO2). Following p14, pups are in room air (21%
FiO2). At p14, in room air the inner retina is vascularized to the ora serrata, whereas in the
ROP model, there is 30% avascular retina. All values are normalized to β-actin and are
compared to p0 which is the same for room air and OIR. There was a significant increase in
expression associated with older developmental age (P<.0001) and with exposure to the
ROP model compared to age-matched room air pups (P<.0001). For graphical
representations, the value of VEGF188 mRNA at p0 was scaled to 1.0 and fold expression of
mRNAs of the splice variants at time points in RA and the ROP model were related to it.
The graph represents means and standard errors for each room air and ROP time point, each
time point having an n=at least 5 retinas from different pups taken from at least 2 litters.
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Real time PCR mean values for VEGF splice variant VEGF120 of rat pups from selected
postnatal days (p) 0 through p18 in room air development (RA) or in the ROP model (ROP).
In the ROP model, p8, p12, and p14 occur immediately following hypoxia (10% FiO2) and
p11 and p13 following hyperoxia (50% FiO2). Following p14, pups are in room air (21%
FiO2). At p14, in room air the inner retina is vascularized to the ora serrata, whereas in the
ROP model, there is 30% avascular retina. All values are normalized to β-actin and are
compared to p0 which is the same for room air and OIR. There was a significant increase in
expression associated with older developmental age (P<.0001) but not with exposure to the
ROP model compared to age-matched room air pups (P=.614). For graphical
representations, the value of VEGF188 mRNA at p0 was scaled to 1.0 and fold expression of
mRNAs of the splice variants at time points in RA and the ROP model were related to it.
The graph represents means and standard errors for each room air and ROP time point, each
time point having an n=at least 5 retinas from different pups taken from at least 2 litters.
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Real time PCR mean values for VEGF splice variant VEGF188 of rat pups from selected
postnatal days (p) 0 through p18 in room air development (RA) or in the ROP model (ROP).
In the ROP model, p8, p12, and p14 occur immediately following hypoxia (10% FiO2) and
p11 and p13 following hyperoxia (50% FiO2). Following p14, pups are in room air (21%
FiO2). At p14, in room air the inner retina is vascularized to the ora serrata, whereas in the
ROP model, there is 30% avascular retina. All values are normalized to β-actin and are
compared to p0 which is the same for room air and OIR. There was no significant
association with older developmental age or with exposure to the ROP model compared to
age-matched room air pups. For graphical representations, the value of VEGF188 mRNA at
p0 was scaled to 1.0 and fold expression of mRNAs of the splice variants at time points in
RA and the ROP model were related to it. The graph represents means and standard errors
for each room air and ROP time point, each time point having an n=at least 5 retinas from
different pups taken from at least 2 litters.
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ELISA measurements of retinal VEGF at time points in room air development (RA) or ROP
model (ROP). There was a significant increase in expression associated with older
developmental age (P<.0001) and with exposure to the ROP model compared to age-
matched room air pups (P<.0001). In Post-hoc testing, VEGF was significantly increased in
the ROP model compared to room air at p14 and p18 (P<.0001). For each time point, an n=
at least 5 retinas from different pups were analyzed from at least 2 different litters.
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